Cancer Targeted Therapy is a type of oncology drug that specifically targets cancer cells, leaving healthy cells unharmed. These drugs are designed to block the growth and spread of cancer cells, and can be used in combination with other treatments such as chemotherapy and radiation. Cancer Targeted Therapy drugs can be divided into two categories: small molecule drugs and monoclonal antibodies. Small molecule drugs are designed to target specific proteins or enzymes that are involved in the growth and spread of cancer cells, while monoclonal antibodies are designed to target specific molecules on the surface of cancer cells.
The Cancer Targeted Therapy market is an important part of the oncology drug market, as it offers a more targeted approach to treating cancer. This type of therapy is becoming increasingly popular due to its ability to reduce side effects and improve patient outcomes.
Some companies in the Cancer Targeted Therapy market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more
